ESC 365 - Should we use angiotensin receptor neprilysin inhibitor for all heart failure patients?

ESC Premium Access

Should we use angiotensin receptor neprilysin inhibitor for all heart failure patients?

Session: Options and challenges for drug therapy of heart failure

Topic: Drug therapy

Speaker: Professor M. Jessup (Dallas, US)

Event: ESC Congress 2017

Congress Presentation

About the speaker

Professor Mariell Jessup

American Heart Association, Dallas (United States of America)

27 presentations

0 follower

3 more presentations in this session

Elderly patients with heart failure: what are the therapeutic options?

Speaker: Professor J. Fang (Salt Lake City, US)

Potentially harmful drugs in patients with chronic heart failure.

Speaker: Professor K. Kjeldsen (Copenhagen, DK)

Drug therapy of heart failure: what is next?

Speaker: Professor E. Braunwald (Boston, US)

Access the full session

Options and challenges for drug therapy of heart failure

Speakers: Professor M. Jessup, Professor J. Fang, Professor K. Kjeldsen, Professor E. Braunwald

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by